Boehringer gets EU marketing approval for lung cancer drug Vargatef

… inhibitor, for the treatment of lung cancer patients. Vargatef in combination with … or locally recurrent non-small cell lung cancer (NSCLC) of adenocarcinoma tumor histology … new treatment option for adult lung cancer patients with advanced adenocarcinoma in …